Inbec Tablet is a fixed-dose combination of Abacavir (600mg), Dolutegravir (50mg), and Lamivudine (300mg), used in the treatment of HIV-1 infection in adults and adolescents.
| Composition | Abacavir (600mg) + Dolutegravir (50mg) + Lamivudine (300mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Strip |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Nextki 100mg Tablet contains Dasatinib, a targeted cancer therapy used to treat certain blood cancers, specifically Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Sofocure V tablet is a combination antiviral medicine containing Sofosbuvir 400mg and Velpatasvir 100mg. It is used for the treatment of chronic Hepatitis C virus (HCV) infection across all six genotypes.
| Composition | Sofosbuvir 400mg + Velpatasvir 100mg |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Hepatitis C |
| Expiry | December 2027 |
Spegra Tablet is a once-daily antiretroviral medication used to treat HIV-1 infection in adults. It combines three powerful ingredients Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) to effectively suppress the HIV virus, reduce its ability to multiply, and strengthen the immune system.
| Composition | Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Twinaqt Tablet is a combination antiretroviral medication containing Dolutegravir (50 mg) and Lamivudine (300 mg). It is used for the treatment of HIV-1 infection in adults and adolescents.
| Composition | Dolutegravir 50mg + Lamivudine 300mg |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in a Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Viropil Tablet is a fixed-dose antiretroviral combination containing Dolutegravir (50 mg), Lamivudine (300 mg), and Tenofovir Disoproxil Fumarate (300 mg). It is used in the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg.
| Composition | Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
